A 54-year-old male patient with liver failure presents with more pronounced ascites, confusion, and vital sign changes indicative of cardiovascular instability. Which nursing intervention is the priority for this patient at this time?

C) Administer lactulose to reduce ammonia levels and improve encephalopathy.

A) Administer intravenous albumin to increase oncotic pressure.

B) Prepare the patient for a paracentesis procedure to remove excess fluid.

C) Administer lactulose to reduce ammonia levels and improve encephalopathy.

D) Initiate a blood transfusion to correct the elevated INR and prevent bleeding.

A 54-year-old male patient with liver failure is exhibiting significant ascites, an increased heart rate, decreased blood pressure, worsening confusion, elevated bilirubin, low albumin, and an elevated INR. Which nursing intervention should be prioritized to address the patient's hepatic encephalopathy?

B) Increase the dose of lactulose to decrease ammonia levels.

A) Administer a diuretic to reduce fluid accumulation.

B) Increase the dose of lactulose to decrease ammonia levels.

C) Provide a high-protein diet to support liver function.

D) Initiate intravenous albumin to improve oncotic pressure.

A patient with liver failure and ascites is being treated for spontaneous bacterial peritonitis (SBP) and hepatic encephalopathy. Despite treatment, the patient's Glasgow Coma Scale (GCS) score has dropped from 14 to 12, and the respiratory rate has increased to 24 breaths per minute. What is the nurse's priority action in this scenario?

C) Notify the healthcare provider about the potential need for intubation.

A) Increase the dosage of lactulose to manage elevated ammonia levels.

B) Administer supplemental oxygen to address increased respiratory rate.

C) Notify the healthcare provider about the potential need for intubation.

D) Reassess the patient's fluid balance and diuretic therapy.

A patient with liver cirrhosis and hepatic encephalopathy is exhibiting increased lethargy, a decrease in Glasgow Coma Scale (GCS) score, and an elevated serum ammonia level. Spontaneous bacterial peritonitis (SBP) has been confirmed, and intravenous cefotaxime has been initiated. Which nursing action is the priority to prevent further complications?

B) Administer lactulose as ordered to reduce ammonia levels.

A) Monitor the patient's intake and output closely to assess fluid balance.

B) Administer lactulose as ordered to reduce ammonia levels.

C) Educate the patient and family about the signs of worsening encephalopathy.

D) Prepare the patient for potential paracentesis to relieve ascitic fluid accumulation.

A patient with spontaneous bacterial peritonitis and hepatic encephalopathy is being treated with intravenous cefotaxime, lactulose, and rifaximin. Despite treatment, his serum ammonia levels remain elevated, and he develops mild jaundice. Which nursing intervention is most appropriate to address the patient's current condition?

C) Monitor the patient's fluid status closely and adjust diuretics to manage ascites.

A) Increase the frequency of lactulose administration to achieve more frequent bowel movements.

B) Encourage the patient to consume a high-protein diet to support liver regeneration.

C) Monitor the patient's fluid status closely and adjust diuretics to manage ascites.

D) Administer additional doses of rifaximin to enhance ammonia clearance.

A patient with spontaneous bacterial peritonitis shows improvement with antibiotic therapy, but continues to have high serum ammonia levels and mild jaundice. Which of the following nursing actions is most appropriate to address the patient's hepatic encephalopathy and liver function?

C) Monitor neurological status closely and adjust lactulose dosage to ensure adequate bowel movements.

A) Increase the dose of furosemide to enhance fluid removal.

B) Administer a protein-rich diet to support liver function.

C) Monitor neurological status closely and adjust lactulose dosage to ensure adequate bowel movements.

D) Encourage increased physical activity to improve circulation and liver function.

A patient with liver failure is exhibiting signs of coagulopathy with an increased prothrombin time (PT) and international normalized ratio (INR). The healthcare team decides to administer vitamin K. Which of the following assessments should the nurse prioritize to evaluate the effectiveness of this intervention?

D) Reviewing the patient's prothrombin time (PT) and INR results

A) Monitoring the patient's blood pressure for stability

B) Checking the patient's hemoglobin and hematocrit levels

C) Observing for a decrease in the patient's serum ammonia levels

D) Reviewing the patient's prothrombin time (PT) and INR results

A patient with liver failure is exhibiting signs of coagulopathy, including an elevated prothrombin time (PT) and international normalized ratio (INR). The healthcare team has administered vitamin K. Which of the following additional interventions would be most appropriate to address the patient's refractory hepatic encephalopathy with elevated serum ammonia levels?

B) Administer lactulose to decrease ammonia levels by promoting bowel movements.

A) Increase the patient's dietary protein intake to support liver function.

B) Administer lactulose to decrease ammonia levels by promoting bowel movements.

C) Withhold rifaximin due to its lack of effectiveness in reducing ammonia levels.

D) Discontinue all medications to prevent further liver stress.

A patient with advanced liver failure is experiencing worsening hepatic encephalopathy and coagulopathy, despite treatment efforts. What is the priority nursing intervention to address his current condition?

A) Administer lactulose to reduce serum ammonia levels.

B) Increase the patient's protein intake to improve nutritional status.

C) Start intravenous fluids to maintain hydration and renal function.

D) Prepare the patient for an urgent liver biopsy to assess liver damage.

A patient with advanced liver failure is being managed for hepatic encephalopathy and coagulopathy. The healthcare team has initiated L-ornithine L-aspartate therapy and is closely monitoring the patient's serum ammonia levels. The patient's neurological status remains unstable with fluctuating confusion and periods of asterixis. Which nursing intervention should be prioritized to address the patient's current condition?

B) Administer lactulose to reduce ammonia levels and monitor bowel movements.

A) Increase dietary protein intake to improve nutritional status.

B) Administer lactulose to reduce ammonia levels and monitor bowel movements.

C) Encourage ambulation to prevent muscle wasting and maintain mobility.

D) Restrict fluid intake to manage potential ascites and fluid overload.

Liver failure - Nursing Case Study

Pathophysiology

• Primary mechanism: Hepatocyte necrosis - Liver failure often begins with the death of liver cells (hepatocytes) due to toxins, viruses, or ischemia, leading to the loss of vital metabolic functions, including detoxification and production of clotting factors.

• Secondary mechanism: Impaired bile flow (cholestasis) - Damage to liver cells and bile ducts causes bile accumulation, leading to jaundice and further hepatocyte damage due to bile acid toxicity.

• Key complication: Portal hypertension - As liver damage progresses, increased resistance to blood flow through the liver can cause elevated pressure in the portal venous system, leading to varices, ascites, and increased risk of bleeding, significantly impacting patient stability and requiring careful monitoring and intervention.

Patient Profile

Demographics:

54-year-old male, construction worker

History:

• Key past medical history: Chronic alcohol use, hepatitis C infection

• Current medications: Lactulose, propranolol

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing abdominal pain and swelling

• Key symptoms: Jaundice, fatigue, confusion, nausea

• Vital signs: Blood pressure 102/68 mmHg, heart rate 96 bpm, respiratory rate 20 breaths per minute, temperature 37.5°C, oxygen saturation 94% on room air

Section 1

As the clinical situation unfolds for this 54-year-old male patient with liver failure, a change in his status becomes apparent during a routine monitoring session. The patient, who initially presented with increasing abdominal pain and swelling, now exhibits more pronounced ascites, evident upon physical examination as significant abdominal distension with shifting dullness. His vital signs reveal a slight increase in heart rate to 104 bpm, while blood pressure has dropped to 98/64 mmHg, indicating possible fluid shifts and cardiovascular instability. The patient's confusion has escalated, raising concerns about worsening hepatic encephalopathy, likely exacerbated by the accumulation of ammonia due to impaired liver function.

Laboratory results further illustrate the deterioration in the patient's condition. Serum bilirubin levels have risen to 4.2 mg/dL (normal range: 0.1-1.2 mg/dL), correlating with the intensification of jaundice. The patient's albumin levels have decreased to 2.3 g/dL (normal range: 3.5-5.0 g/dL), reflecting impaired synthetic function of the liver and contributing to the development of ascites due to decreased oncotic pressure. Additionally, an elevated INR of 1.8 (normal range: 0.8-1.2) suggests a heightened risk of bleeding, necessitating careful monitoring and consideration of prophylactic measures to prevent variceal hemorrhage.

These findings indicate that the patient's liver failure is advancing, with significant implications for his clinical management. The development of moderate ascites and increased encephalopathy highlights the need for adjustments in his therapeutic regimen, possibly including diuretics to manage fluid accumulation and lactulose titration to address encephalopathy. This shift in the patient's condition also emphasizes the importance of ongoing surveillance for further complications, such as spontaneous bacterial peritonitis or variceal bleeding, which could necessitate urgent interventions. The healthcare team must engage in thorough clinical reasoning to prioritize interventions that stabilize the patient's current state and mitigate further progression of liver failure.

Section 2

As the healthcare team continues to monitor the patient closely, a noticeable change in his status becomes evident. Despite the initial adjustments to his therapeutic regimen, including the introduction of furosemide and spironolactone to manage ascites and titration of lactulose for encephalopathy, the patient exhibits increasing signs of discomfort and distress. During a subsequent assessment, the patient is found to be more lethargic, with a GCS score dropping to 12 from a previous 14, indicating a decline in his neurological status. His respiratory rate has increased to 24 breaths per minute, suggesting potential respiratory compromise, possibly due to the distended abdomen impeding diaphragmatic movement.

New diagnostic results reveal a further elevation in serum ammonia levels, now at 180 µmol/L (normal range: 15-45 µmol/L), underscoring the worsening hepatic encephalopathy. In addition, a diagnostic paracentesis is performed due to concerns of spontaneous bacterial peritonitis (SBP), given the rapid accumulation of ascitic fluid and the patient's clinical presentation. The ascitic fluid analysis shows a white blood cell count of 350 cells/mm³ with a predominance of neutrophils, and a positive culture for Escherichia coli, confirming SBP.

This new complication demands prompt intervention to prevent further deterioration. The healthcare team initiates empirical antibiotic therapy, starting with intravenous cefotaxime, targeting the bacterial infection. The priority now is to stabilize the patient by addressing the SBP, monitoring for potential sepsis, and continuing to manage the hepatic encephalopathy through careful titration of lactulose and consideration of additional agents like rifaximin. The team must also revisit the patient's fluid management plan to minimize circulatory dysfunction while carefully balancing diuresis and maintaining hemodynamic stability. This evolving scenario calls for vigilant monitoring and dynamic clinical reasoning to navigate the complexities of the patient's liver failure and associated complications.

Section 3

Response to Interventions

Following the initiation of intravenous cefotaxime to address the confirmed spontaneous bacterial peritonitis, the healthcare team closely monitors the patient's response. Within 48 hours, there are encouraging signs of improvement. The patient's temperature, previously elevated, begins to normalize, indicating a positive response to the antibiotic therapy. However, his neurological status remains a concern, as his Glasgow Coma Scale (GCS) score fluctuates between 11 and 12, suggesting persistent hepatic encephalopathy. The team continues to titrate lactulose with the goal of achieving two to three soft bowel movements per day, which is crucial for reducing ammonia levels. Despite this, his serum ammonia remains high at 160 µmol/L, necessitating the addition of rifaximin to further target the encephalopathy.

In terms of respiratory status, the patient's respiratory rate has decreased slightly to 22 breaths per minute, but he still requires supplemental oxygen to maintain adequate saturation levels. The distended abdomen continues to pose challenges, contributing to his respiratory compromise. The healthcare team decides to adjust his diuretic regimen, cautiously increasing the doses of furosemide and spironolactone to facilitate more effective fluid removal while monitoring renal function and electrolyte balance closely. Renal function tests indicate stable creatinine levels, suggesting that the kidneys are tolerating the diuretic therapy well.

Despite these interventions, new complications arise as the patient develops mild jaundice, with total bilirubin levels rising to 3.5 mg/dL (normal range: 0.1-1.2 mg/dL), pointing to worsening liver function. This necessitates a reevaluation of the overall management plan, including potential adjustments in medication and supportive care strategies. The team remains vigilant for any signs of further deterioration, understanding that the patient's journey will require continuous assessment and dynamic clinical reasoning to navigate the complexities of his liver failure and associated complications. This evolving situation underscores the importance of a coordinated, multidisciplinary approach to optimize outcomes.

Section 4

The following day, the healthcare team notes a change in the patient's status as he begins to exhibit signs of coagulopathy, a common complication in liver failure. His prothrombin time (PT) has increased to 18 seconds (normal range: 11-13.5 seconds) and his international normalized ratio (INR) has risen to 1.8 (normal range: 0.8-1.2), indicating a reduced ability to form blood clots. This increase poses a risk for bleeding and necessitates a careful reassessment of his anticoagulation status, especially considering his ongoing ascites management and potential procedures like paracentesis. The team decides to administer vitamin K to help support clotting factor synthesis, while simultaneously monitoring for any signs of bleeding, such as overt bleeding or a drop in hemoglobin levels.

Additionally, the patient's neurological status fluctuates further, with intermittent episodes of confusion and disorientation. Despite the addition of rifaximin, his serum ammonia level remains elevated at 155 µmol/L. This persistent hyperammonemia suggests refractory hepatic encephalopathy, prompting the team to consider further interventions. The healthcare providers discuss the potential benefits of alternative therapies, such as L-ornithine L-aspartate, to enhance ammonia detoxification. They also emphasize the importance of maintaining a low-protein diet to reduce ammonia production from dietary sources.

As they address these complications, the team remains cognizant of the delicate balance required in managing the patient's condition. They continue to closely monitor his vital signs, noting a stable blood pressure at 110/70 mmHg but a heart rate elevated to 98 beats per minute, likely in response to his systemic stress. This evolving clinical picture necessitates ongoing interdisciplinary collaboration, with input from hepatology, nutrition, and pharmacology specialists, to optimize his care plan and improve his prognosis. The patient’s journey highlights the complexity of managing liver failure and the critical role of dynamic clinical reasoning in adapting to new challenges.

Section 5

In the days following the administration of vitamin K and the implementation of a low-protein diet, the healthcare team observes a partial improvement in the patient's coagulation profile. His prothrombin time decreases to 16 seconds, and his INR drops slightly to 1.6. While these changes suggest some improvement in clotting ability, the patient remains at risk for bleeding, necessitating continued vigilance. Concurrently, the patient's hemoglobin level has decreased to 10 g/dL from a previous 11.5 g/dL, prompting the team to reassess for potential sources of bleeding, such as gastrointestinal bleeding, which could exacerbate his condition.

Despite these efforts, the patient's neurological status continues to fluctuate. His episodes of confusion have become more frequent, and he now experiences brief periods of asterixis, indicating worsening hepatic encephalopathy. The healthcare team opts to initiate L-ornithine L-aspartate therapy, aiming to enhance ammonia detoxification and improve his mental status. Meanwhile, they maintain a watchful eye on his serum ammonia levels, which remain elevated at 145 µmol/L, and assess for any signs of improvement in his cognitive function.

As the clinical picture evolves, the interdisciplinary team discusses the potential need for more aggressive interventions, such as consideration for liver transplantation evaluation, given the refractory nature of his encephalopathy and ongoing coagulopathy. The team also emphasizes the need for close monitoring of renal function, recognizing the potential risk for hepatorenal syndrome, as evidenced by a slight increase in serum creatinine to 1.4 mg/dL. These developments underscore the complexity of managing advanced liver failure, highlighting the importance of proactive clinical reasoning and timely adjustments to the patient's care plan.